Drug intelligence / Profile preview

furosemide + human chorionic gonadotropin

Development stage: Unknown
Lead developer: Sanofi
Modality: Small Molecules
Administration: Oral, Intravenous, Intramuscular, Subcutaneous

Overview

This appears to be a combination of two separate drugs with different mechanisms of action and uses. **Furosemide** is a loop diuretic that works by causing the kidneys to eliminate excess water and salt from the body. It's used to treat edema associated with congestive heart failure, cirrhosis, and renal disease, as well as hypertension. **Human chorionic gonadotropin (HCG)** is a hormone used in fertility treatments for women and to help with testosterone and sperm production in men, as well as treating cryptorchidism in male children.

Targets

LHCGR (Luteinizing hormone/choriogonadotropin receptor)NKCC2 (Sodium-potassium-chloride cotransporter 2)NKCC (Sodium-potassium-chloride cotransporter)

Beyond the preview

Go deeper on furosemide + human chorionic gonadotropin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on furosemide + human chorionic gonadotropin.